Basic hematological tests as inflammatory performance markers of patients treated either by conservative surgery or minor amputation for infected diabetic foot ulcers.
Kaissar YammineGhadi Bou OrmJoseph MouawadChahine AssiPublished in: Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society (2023)
Basic inflammatory markers have been extensively studied to differentiate between non-infected and infected diabetic foot ulcers (DFU). Very rarely, basic hematological tests such as white cell count (WCC) and platelet counts were used as performance markers for DFU infection severity. The aim is to investigate these biomarkers in patients with DFU treated exclusively with surgery. In this retrospective comparative study, we included 154 procedures comparing a conservative surgery group (n = 66 for infected DFU) and a minor amputation group (n = 88 for infected DFU with osteomyelitis). Outcomes were set as the preoperative values of: WCC, neutrophils (N), lymphocytes (L), Monocytes (M), Platelets (P), red cell distribution width (RDW) and the ratios N/L, L/M, and P/L. Area under curve (AUC) of the receiver operating characteristic (ROC) was calculated based on the diagnosis of minor amputation as a positive result. Cutoff point values with the highest sensitivity and specificity was obtained for each outcome. The highest AUC values were for WCC (0.68), neutrophils (0.68), platelets (0.7) and P/L ratio (0.69) with corresponding cut-off values of 10650/mm3, 76%, 234000/mcL, and 265, respectively. The highest sensitivity was for the platelet count (81.5%) while the highest specificity was for L/M (89%) and P/L ratios (87%). Postoperative values showed similar results. Simple routine blood tests could serve as inflammatory performance markers to help predict the severity of infection in patients treated surgically for infected DFU. This article is protected by copyright. All rights reserved.
Keyphrases
- minimally invasive
- coronary artery bypass
- peripheral blood
- lower limb
- patients undergoing
- single cell
- oxidative stress
- type diabetes
- stem cells
- surgical site infection
- cell therapy
- coronary artery disease
- metabolic syndrome
- mesenchymal stem cells
- wound healing
- bone marrow
- atrial fibrillation
- adipose tissue
- peripheral artery disease
- skeletal muscle
- glycemic control